October 7, 2009
For Immediate Release

Contact: Julia Bey Ahmet
(973) 463-9600 ext. 303

Community Hope’s Annual Gala Honors Pharma and Biotechnology Leaders

Sparkle of Hope Charity Event to Benefit Homeless Veterans and Individuals in Recovery from Mental Illness

John Crowley (L), President and CEO of Amicus Therapeutics, and Dr. Stuart Peltz, President and CEO of PTC Therapeutics Inc., pay special tribute to Fred Hassan (R), Chairman and CEO of the Schering-Plough Corporation

Parsippany, NJ -- Community Hope will host its Annual Sparkle of Hope Dinner Auction on Tuesday, October 27, 2009 at 6 p.m. at the Birchwood Manor in Whippany, New Jersey. The annual charity event benefits Community Hope’s residential programs for hundreds of young adults and individuals in recovery from mental illness and substance abuse, including the nationally-acclaimed Hope for Veterans Program for homeless veterans.

As many as 500 guests are expected to attend this year to honor John Crowley, President and CEO of Amicus Therapeutics, and Dr. Stuart Peltz, President and CEO of PTC Therapeutics Inc., and to pay special tribute to Fred Hassan, Chairman and CEO of the Schering-Plough Corporation, who founded the gala thirteen years ago, announced Dr. Sol Barer, Chairman and CEO of Celgene and the 2009 Honorary Chair.

“Mr. Hassan will be presented with a special award for his vision in founding the event in 1997 and the $4.5 million which the event has raised over the past 13 years in support of expanding programs and services for individuals with mental illness,” said Dr. Barer, who will be presenting Mr. Hassan with the award.

Dr. Barer will also be presenting awards to Mr. Crowley and Dr. Peltz in recognition of their cutting edge research into debilitating and chronic illnesses. Dr. Barer said their contributions to medical research and treatment are evidence that we can tackle the most challenging illnesses.

Joining Dr. Barer in chairing this year’s gala are David Norton, Company Group Chairman of Global Pharmaceuticals for Johnson & Johnson; Cavan Redmond, President of Wyeth Consumer Healthcare; and Kevin Rigby, Vice President of Public Affairs and Communications for Novartis Pharmaceuticals Corporation.

Mr. Hassan’s long career in the pharmaceutical industry began at Sandoz Pharmaceuticals, now Novartis, where he served as head of its U.S. pharmaceuticals business and held various positions during his 17 years with the company. He joined American Home Products, now Wyeth, where he served as Executive Vice President and was elected to Wyeth’s Board of Directors in 1995. In May 1997, Mr. Hassan joined the former Pharmacia & Upjohn as CEO and would later be named Chairman and CEO of the Pharmacia Corporation. Since April 2003, he has served as Chairman and CEO of the Schering-Plough Corporation.

Honoree John Crowley’s life story is being featured in an upcoming movie. His involvement with biotechnology stems from the 1998 diagnosis of two of his children with Pompe disease - a fatal neuromuscular disorder. Mr. Crowley and his family have also been featured on the cover of The Wall Street Journal and on The Today Show, CNBC and The Paula Zahn Show. He became president and CEO of Amicus in January 2005, and previously served as founding president and CEO of Orexigen Therapeutics. Preceding Orexigen, Mr. Crowley was senior vice president at Genzyme Therapeutics and served as the founding president and CEO of Novazyme that was developing a novel treatment for Pompe disease. He previously served in several senior management roles with the Bristol-Myers Squibb Company and began his professional career as a litigation associate in the Health Care Practice Group of Bingham, Summers, Welsh & Spilman.

Dr. Peltz is a co-founder of PTC, a member of the board of directors and President and Chief Executive Officer since the company's inception in 1998. Prior to founding PTC, Dr. Peltz was a Professor in the Department of Molecular Genetics and Microbiology at the University of Medicine and Dentistry of New Jersey. He has published over 80 publications in the area of post-transcriptional control processes.

Event sponsors help to make the fundraising event possible. The top-tier Presenting Sponsors are Celgene Corporation; the Johnson & Johnson Family of Companies; Novartis Pharmaceuticals Corporation and Schering-Plough Corporation and the Diamond Sponsors are Goldman, Sachs & Co.; Lowenstein Sandler PC; Merck & Co.; the Pharmaceutical Research & Manufacturers of America (PhRMA) and Wyeth.

Gala activities include a raffle drawing for vacation packages; a 50/50 cash raffle and a silent auction featuring original artwork and autographed sports memorabilia. In addition, guests can participate in a raffle for chances to win nearly fifty other prizes.

Table prices range from $5,000 to $25,000. Individual tickets can be purchased for $140 per person. For more information on the Sparkle of Hope Dinner Auction, visit the events section of Community Hope’s website at or call the Development Office at (973) 463-9600, extension 308.